Literature DB >> 30454788

Oral Cavity Cancer.

Kyle S Ettinger1, Laurent Ganry2, Rui P Fernandes3.   

Abstract

Management of oral cavity squamous cell carcinoma has become increasingly driven by emerging evidence as a result of the improved quality of clinical research associating clinicopathologic risk factors with oncologic and survival outcomes. Multiple significant recent changes to treatment guidelines and staging algorithms for oral cavity squamous cell carcinoma reflect evolving understanding of tumor biology and the need for adequately extensive treatment of aggressive disease. This article provides clinicians with a synopsis of the most contemporary management strategies for oral cavity squamous cell carcinoma, framed within the context of historical treatment philosophies.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AJCC staging; Anatomic subsite; Depth of invasion; Maxillofacial surgery; NCCN guidelines; Neck dissection; Oral cavity cancer; Squamous cell carcinoma

Mesh:

Year:  2018        PMID: 30454788     DOI: 10.1016/j.coms.2018.08.002

Source DB:  PubMed          Journal:  Oral Maxillofac Surg Clin North Am        ISSN: 1042-3699            Impact factor:   2.802


  17 in total

1.  Oral Cancer: Integration of Studies for Diagnostic and Therapeutic Precision.

Authors:  N J D'Silva; J S Gutkind
Journal:  Adv Dent Res       Date:  2019-11

2.  Association between interleukin-10 gene polymorphisms and risk of oral carcinoma: A meta-analysis.

Authors:  Fan Li; Xing Xu; Chao Xuan; Wan-Tao Chen
Journal:  Histol Histopathol       Date:  2020-10-29       Impact factor: 2.303

3.  Evaluation of the Cytotoxic Activity of the Usnea barbata (L.) F. H. Wigg Dry Extract.

Authors:  Violeta Popovici; Laura Adriana Bucur; Verginica Schröder; Daniela Gherghel; Cosmin Teodor Mihai; Aureliana Caraiane; Florin Ciprian Badea; Gabriela Vochița; Victoria Badea
Journal:  Molecules       Date:  2020-04-17       Impact factor: 4.411

Review 4.  Head and neck cancer management and cancer stem cells implication.

Authors:  Osama A Elkashty; Ramy Ashry; Simon D Tran
Journal:  Saudi Dent J       Date:  2019-06-10

5.  Association of a multiple-step action with cervical lymph node yield of oral cancer patients in an Asian country.

Authors:  Ching-Chieh Yang; Bor-Hwang Kang; Wen-Shan Liu; Chun-Hao Yin; Ching-Chih Lee
Journal:  BMC Oral Health       Date:  2021-01-13       Impact factor: 2.757

Review 6.  Biomaterial-based strategies for maxillofacial tumour therapy and bone defect regeneration.

Authors:  Bowen Tan; Quan Tang; Yongjin Zhong; Yali Wei; Linfeng He; Yanting Wu; Jiabao Wu; Jinfeng Liao
Journal:  Int J Oral Sci       Date:  2021-03-16       Impact factor: 6.344

Review 7.  Systems genetics analysis of oral squamous cell carcinoma susceptibility using the mouse model: current position and new perspective.

Authors:  Aysar Nashef; Nayrouz Qahaz; Imad Abu El-Naaj; Fuad A Iraqi
Journal:  Mamm Genome       Date:  2021-06-21       Impact factor: 2.957

8.  A non-toxic, reversibly released imaging probe for oral cancer that is derived from natural compounds.

Authors:  Magda Ghanim; Nicola Relitti; Gavin McManus; Stefania Butini; Andrea Cappelli; Giuseppe Campiani; K H Mok; Vincent P Kelly
Journal:  Sci Rep       Date:  2021-07-07       Impact factor: 4.379

9.  Salvage surgery for patients with residual/persistent diseases after improper or insufficient treatment of oral squamous cell carcinoma: can we rectify these mistakes?

Authors:  Yue He; Zhonglong Liu; Surui Sheng; Weijin Gao; Xiao Tang; Xiaoguang Li; Chunyue Ma
Journal:  BMC Cancer       Date:  2021-07-31       Impact factor: 4.430

10.  Design of a nanostructured mucoadhesive system containing curcumin for buccal application: from physicochemical to biological aspects.

Authors:  Sabrina Barbosa de Souza Ferreira; Gustavo Braga; Évelin Lemos Oliveira; Jéssica Bassi da Silva; Hélen Cássia Rosseto; Lidiane Vizioli de Castro Hoshino; Mauro Luciano Baesso; Wilker Caetano; Craig Murdoch; Helen Elizabeth Colley; Marcos Luciano Bruschi
Journal:  Beilstein J Nanotechnol       Date:  2019-11-25       Impact factor: 3.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.